What did @gdagg actually say?
The creator's argument is essentially a gym-culture complaint: people with less than a year of training are skipping the basics, jumping straight to peptides (specifically mentioning something called "red" and referencing "gear" and "t-code"), and then crediting their results to being "built for this" rather than acknowledging the compounds. It's a rant about shortcuts, not a clinical breakdown. That context matters.
The core claim is that peptide use among beginners is widespread, that it replaces rather than supplements effort, and that results from peptides are somehow less legitimate than results from "hard work." There's also a blurry conflation happening here between peptides, anabolic steroids ("gear"), and what sounds like testosterone ("t-code"). Those are not the same category of compound, and mixing them in one breath muddles the actual conversation.
Does the science back this up?
The cultural observation, that gym beginners are increasingly turning to performance-enhancing compounds before establishing a training foundation, is supported by survey data. A 2021 review in Sports Medicine (Sagoe et al.) found that anabolic-androgenic steroid use is skewing younger, with initiation sometimes occurring within the first year of training. That part checks out.
Where it gets complicated is the peptide side. Research-grade peptides like BPC-157 and TB-500 have been studied primarily for tissue repair in animal models. A 2018 paper in Current Pharmaceutical Design (Chang et al.) showed BPC-157 accelerated tendon healing in rodents, but human clinical trial data is thin. These compounds are not the same as anabolic steroids in mechanism or risk profile. Lumping "peptides" with "gear" as equivalent shortcuts is scientifically sloppy. GHK-Cu, Semax, and CJC-1295 all have distinct mechanisms, distinct risk profiles, and distinct evidence bases. Treating them as one category is not accurate.
What did they get wrong (or right)?
Credit where it's due: the frustration about skipping foundational training is legitimate. Exercise science is clear that untrained individuals have dramatic neurological and hypertrophic adaptation capacity without any supplementation. A 2016 meta-analysis in the Journal of Strength and Conditioning Research (Schoenfeld et al.) confirmed that beginners can achieve significant strength and muscle gains within the first year on resistance training alone. Bypassing that adaptation window with compounds before understanding your own baseline response is genuinely poor practice.
But here's where the rant breaks down. Peptides used in legitimate clinical contexts, such as growth hormone secretagogues like ipamorelin or CJC-1295, are not the same as taking anabolic steroids. The creator says "it's only peptides and gear" as if they're interchangeable. They are not. Conflating compounds with entirely different mechanisms, regulatory statuses, and risk profiles in a 92,000-view video is the kind of thing that spreads misinformation even when the underlying sentiment is reasonable.
What should you actually know?
Peptides are a broad and heterogeneous category. Some, like MK-677, interact with the ghrelin receptor to stimulate growth hormone release. Others, like BPC-157, are being researched for anti-inflammatory and healing properties. None of them replace progressive overload, caloric adequacy, and sleep as the primary drivers of body composition change. That is not an opinion; it is supported by decades of exercise physiology research.
If you are a beginner considering peptides for performance or aesthetics, the honest answer from the literature is: the evidence base for most of these compounds in healthy, trained humans is limited, and you have not yet established the physiological baseline needed to even know if a compound is doing anything. Starting with fundamentals is not old-fashioned advice. It is what the data actually supports.
- Peptides are not a monolith. BPC-157, ipamorelin, and GHK-Cu have different mechanisms and different evidence bases.
- Conflating peptides with anabolic steroids misleads people in both directions.
- Beginners have the highest rate of "untrained adaptation," meaning the most to gain from training alone.
- Legitimate clinical use of peptides exists. Dismissing an entire category because of misuse culture oversimplifies real ongoing research.